Opioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk among Young Adult Immigrants from the Former Soviet Union Living in New York City

Journal of Addictive Diseases

Volumn 34, Issue 2-3, 2015, Pages 162-177

  Guarino, Honoria ^a   Marsch, Lisa A ^b   Deren, Sherry ^c   Straussner, Shulamith L A ^d   Teper, Anastasia ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

drug use trajectories; Former Soviet Union immigrants; HCV risk; injection risk behavior; prescription opioid misuse; transition to heroin; transition to injection; young injectors

Indexed keywords

BUPRENORPHINE; CODEINE; DIAMORPHINE; HYDROCODONE; HYDROMORPHONE; METHADONE; NALTREXONE; OPIATE; OXYCODONE; OXYMORPHONE;

ADULT; ARTICLE; BELARUS; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG USE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLNESS TRAJECTORY; IMMIGRANT; LATVIA; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PATIENT COUNSELING; PRESCRIPTION; RUSSIAN FEDERATION; SELF REPORT; STRUCTURED INTERVIEW; UKRAINE; UNITED STATES; USSR; UZBEKISTAN; ADOLESCENT; ETHNOLOGY; HIV INFECTIONS; MIGRANT; NEW YORK; OPIOID-RELATED DISORDERS; QUALITATIVE RESEARCH; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; EMIGRANTS AND IMMIGRANTS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; NEW YORK CITY; OPIOID-RELATED DISORDERS; QUALITATIVE RESEARCH; RISK FACTORS; RISK-TAKING; SELF REPORT; SUBSTANCE ABUSE, INTRAVENOUS; USSR; YOUNG ADULT;

EID: 84940200548     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2015.1059711     Document Type: Article

References (50)

1. U. S. Census Bureau. 2005-2009 American Community Survey 5-year estimates. Table B05006: Place of birth for the foreign-born population. Washington, DC: Author, 2010.
2. Guarino H, Moore SK, Marsch LA, Florio S. The social production of substance abuse and HIV/HCV risk: an exploratory study of immigrants from the former Soviet Union living in New York City. Subst Abuse Treat Prev Policy 2012; 7:2.
3. Isralowitz R, Straussner SLA, Rosenblum A. Drug abuse, risk of infectious diseases, and service utilization among former Soviet Union immigrants: a view from New York City. J Ethn Subst Abuse 2006; 5:91-6.
4. Spunt B. The current New York City heroin scene. SubstUseMisuse 2003; 38:1539-49.
5. Hamid A, Curtis R, McCoy K, et al. The heroin epidemic in New York City: current status and prognoses. J Psychoactive Drugs 1997; 29:375-91.
6. Harocopos A, Goldsamt LA, Kobrak P, et al. New injectors and the social context of injection initiation. Int J Drug Policy 2009; 20:317-23.
7. Isralowitz R, Straussner SLA, Vogt I, Chtenguelov V. A preliminary exploration of immigrant substance abusers from the former Soviet Union living in Israel, Germany, and the United States: a multinational perspective. In: Straussner SLA, L Harrison, eds. International aspects of social work practice in the addictions. Philadelphia: The Haworth Press, 2002.
8. Geroviche A, Schneider J. Personal communication, July 2011. Carlini K. Personal communication, September 2013.
9. Fuller CM, Vlahov D, Latkin CA, et al. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. JAIDS 2003; 32:86-93.
10. Goldsamt LA, Harocopos A, Kobrak P, et al. Circumstances, pedagogy, and rationales for injection initiation among new drug injectors. J Comm Health 2010; 35:258-67.
11. Batash S, Khaykis I, Raicht RF, Bini EJ. High prevalence of hepatitis C virus infection among immigrants from the former Soviet Union in the New York City metropolitan area: results of a community-based screening program. Am J Gastroenterol 2008; 103:922-27.
12. Ditah I, Ditah F, Devaki P, et al. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol 2014; 60:691-98.
13. Paone D, O'Brien DB, Shah S, Heller D. Epi data brief: opioid analgesics in New York City: misuse, morbidity, and mortality update. New York: New York City Department of Health and Mental Hygiene, 2011.
14. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Author, 2013.
15. Jones C. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend 2013; 132:95-100.
16. Mars SG, Bourgois P, Karandinos G, et al. "Every 'never' I ever said came true:" transitions from opioid pills to heroin injecting. Int J Drug Policy 2013; 25:257-66.
17. Mateu-Gelabert P, Guarino H, Jessell L, Teper A. Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. J Subst Abuse Treat 2014. http://dx. doi. org/10. 1016/j. jsat. 2014. 07. 002. [Epub ahead of print].
18. Frank D, Mateu-Gelabert P, Guarino H, et al. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. Int J Drug Policy 2014. http://dx. doi. org/10. 1016/j. drugpo. 2014. 07. 013. [Epub ahead of print].
19. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 2014; 71:821-26.
20. Centers for Disease Control and Prevention. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users-New York, November 2004-April 2007. MMWR 2008; 57:517-21.
21. Centers for Disease Control and Prevention. Hepatitis C virus infection among adolescents and young adults-Massachusetts, 2002-2009. MMWR 2011; 60:537-41.
22. Centers for Disease Control and Prevention. Risk factors for hepatitis C virus infections among young adults-Massachusetts, 2010. MMWR 2011; 60:1457-58.
23. Centers for Disease Control and Prevention. Hepatitis C virus infection among young adults-rural Wisconsin, 2010. MMWR 2012; 61:358.
24. Zibbell JE, Hart-Malloy R, Barry J, et al. Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health 2014; 104:2226-32.
25. Boggs W. Increasing rates of acute hepatitis C virus infection among young Americans. Medscape. September 1, 2014. http:// www. medscape. com/viewarticle/830754-print. (accessed September 3, 2014).
26. Suryaprasad AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young non-urban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis 2014. [Epub ahead of print].
27. MacGibbon E, Bornschlegel K. Highlights of new hepatitis C surveillance projects at the NYC Department of Health and Mental Hygiene. Presented at the 2014 NYC Hepatitis C Research Consortium Meeting, >New York, September 29, 2014.
28. Hagan H, Pouget ER, Willimas IT, et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis 2010; 201:378-85.
29. Doerrbecker J, Friesland M, Ciesek S, et al. Inactivation and survival of hepatitis C virus on inanimate surfaces. J Infect Dis 2011; 204:1830-8.
30. Doerrbecker J, Behrendt P, Mateu-Gelabert P, et al. Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment. J Infect Dis 2013; 207:281-7.
31. Buxton MB, Vlahov D, Strathdee SA, et al. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend 2004; 75:177-83.
32. Grebely J, Dore GJ. Prevention of hepatitis C virus in injection drug users: a narrow window of opportunity. J Infect Dis 2011; 203:571-4.
33. Hagan H, Pouget ER, DesJarlais DC, Lelutiu-Weinberger C. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol 2008; 168:1099-109.
34. Patton MQ. Qualitative research and evaluation methods, 3rd ed., Thousand Oaks, CA: Sage Publications Inc., 2001.
35. Tashakkori A, Teddlie C. Mixed methodology: combining qualitative and quantitative approaches, applied social research methods series, vol. 46. Thousand Oaks, CA: Sage Publications, 1998.
36. Centers for Disease Control and Prevention. National HIV behavioral surveillance study. IDU 3 data collection instrument. Atlanta: Author, 2012.
37. HIV/AIDS Prevention Research Division. Risk assessment battery (RAB). Department of Psychiatry, Penn Behavioral Health, University of Pennsylvania. http://www. med. upenn. edu/hiv/user-documents/RABv2. 112. 21. 95-2. doc. (accessed August 1, 2011).
38. Kang S-Y, Deren S, Andía J, et al. Egocentric HIV risk networks among Puerto Rican crack users in New York and Puerto Rico: impact on sex risk behaviors over time. AIDS Educ Prev 2005; 17:53-67.
39. Friedman SR, Bolyard M, Sandoval M, et al. The relative prevalence of different STIs in HIV-discordant sexual partnerships: data from a risk network study in a highrisk New York neighborhood. Sex Transm Infect 2008; 84:17-8.
40. Khan MR, Epperson M, Mateu-Gelabert P, et al. Incarceration, sex with an STI-or HIV-infected partner, and infection with an STI or HIV in Bushwick, Brooklyn, NY: a social network perspective. Am J Public Health 2011; 101:1110-7.
41. O'Grady CL, Surratt HL, Kurtz SP, Levi-Minzi MA. Nonmedical prescription drug users in private versus public substance abuse treatment: a cross-sectional comparison of demographic and HIV risk behavior profiles. Subst Abuse Treat Prev Policy 2014; 9:9.
42. Daniulaityte R, Falck, R, Carlson RG. "I'm not afraid of those ones just 'cause they've been prescribed:" perceptions of risk among illicit users of pharmaceutical opioids. Int J Drug Policy 2012; 23: 374-84.
43. Lankenau SE, Teti M, Silva K, et al. Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy 2012; 23:37-44.
44. Peavy KM, Banta-Green CJ, Kingston S, et al. "Hooked on" prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J Psychoactive Drugs 2012; 44:259-65.
45. Johnson KM, Fibbi M, Langer D, et al. Prescription drug misuse and risk behavior among young injection drug users. J Psychoactive Drugs 2013; 45:112-21.
46. Evans JL, Hahn JA, Lum PJ, et al. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO study). Drug Alcohol Depend 2009; 101:152-7.
47. Hussey JM, Hallfors DD, Waller MW, et al. Sexual behavior and drug use among Asian and Latino adolescents: association with immigrant status. J Immigr Health 2007; 9:85-94.
48. Turner RJ, Lloyd DA, Taylor J. Stress burden, drug dependence, and the nativity paradox among U. S. Hispanics. Drug Alcohol Depend 2006; 83:79-89.
49. Blake SM, Ledsky R, Goodenow C, O'Donnell L. Recency of immigration, substance use, and sexual behavior among Massachusetts adolescents. Am J Public Health 2001; 91:794-8.
50. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatol 2001; 34:180-237.